Karen Krasney Insider Trades & Stock Holdings
Karen Krasney, EVP, GENERAL COUNSEL at Capricor Therapeutics, Inc. has 4 Form 4 trades on file since Jun 22, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($12K), net -$12K. Latest filing: disposed of 24.10K shares of $CAPR on Jun 25, 2026.
- Trades on file
- 4
- Open-market bought
- $0
- Open-market sold
- $12K
- Net open-market
- -$12K
- Latest filing
- Jun 25, 2026
All insider trades by Karen Krasney
| Date | Ticker | Type | Shares | Price | Value | Owned after | ΔOwn | 1W | 1M | 6M | Role | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $CAPR | Sell (Option exercise) | 24.10K | $0 | — | -23.7% | -77.0% | EVP, GENERAL COUNSEL | Read | |||||
| $CAPR | Sell (Open-market sale) | 400 | $30 | $12K | -21.8% | -33.2% | EVP, GENERAL COUNSEL | Read | |||||
| $CAPR | Buy (Option exercise) | 400 | $3.18 | $1.27K | -21.8% | -33.2% | EVP, GENERAL COUNSEL | Read | |||||
| $CAPR | Sell (Option exercise) | 500 | $0 | — | -18.9% | -35.5% | EVP, GENERAL COUNSEL | Read |
"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.
Stocks Karen Krasney traded
Frequently asked questions
Has Karen Krasney been buying or selling stock?
Karen Krasney has 0 open-market purchases and 1 open-market sale on file, net -$12K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.
What was Karen Krasney's latest insider trade?
disposed of 24.10K shares of $CAPR on Jun 25, 2026.
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.
SMS Terms
By entering your mobile number and tapping the sign-up button, you provide express written consent to receive recurring automated text messages from TradeTexts at that number, including stock alerts about SEC filings, insider and congress trades, analyst ratings, hedge fund moves, and earnings results. Consent is not a condition of any purchase. Message frequency varies. Messages are not investment advice. Message and data rates may apply. Reply HELP for help and STOP to opt out at any time. See our Terms and Privacy Policy.